GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SRTOY) » Definitions » Other Financing

SRTOY (Sartorius Stedim Biotech) Other Financing : $-266 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Sartorius Stedim Biotech Other Financing?

Sartorius Stedim Biotech's Other Financing for the three months ended in Dec. 2024 was $-7 Mil.

Sartorius Stedim Biotech's Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 was $-266 Mil.


Sartorius Stedim Biotech Other Financing Historical Data

The historical data trend for Sartorius Stedim Biotech's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Other Financing Chart

Sartorius Stedim Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -41.43 -10.74 -55.51 -223.88 -186.18

Sartorius Stedim Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -111.12 -9.13 -101.83 -147.73 -6.91

Sartorius Stedim Biotech Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-266 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sartorius Stedim Biotech Other Financing Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius Stedim Biotech Business Description

Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.

Sartorius Stedim Biotech Headlines

From GuruFocus

Q3 2021 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2020 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Preliminary Q4 2019 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2021 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2020 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Nine-month results 2022 of Sartorius Stedim Biotech

By PRNewswire PRNewswire 10-19-2022